1606 related articles for article (PubMed ID: 21633179)
1. Inflammatory links between obesity and metabolic disease.
Lumeng CN; Saltiel AR
J Clin Invest; 2011 Jun; 121(6):2111-7. PubMed ID: 21633179
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.
Tam CS; Redman LM
Horm Mol Biol Clin Investig; 2013 Sep; 15(1):19-24. PubMed ID: 25436729
[TBL] [Abstract][Full Text] [Related]
3. Nutrient regulation of inflammatory signalling in obesity and vascular disease.
Palmer TM; Salt IP
Clin Sci (Lond); 2021 Jul; 135(13):1563-1590. PubMed ID: 34231841
[TBL] [Abstract][Full Text] [Related]
4. Inflammation in obesity-related diseases.
O'Rourke RW
Surgery; 2009 Mar; 145(3):255-9. PubMed ID: 19231576
[No Abstract] [Full Text] [Related]
5. Visceral fat and insulin resistance - what we know?
Janochova K; Haluzik M; Buzga M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):19-27. PubMed ID: 30398218
[TBL] [Abstract][Full Text] [Related]
6. Celastrol attenuates inflammatory responses in adipose tissues and improves skeletal muscle mitochondrial functions in high fat diet-induced obese rats via upregulation of AMPK/SIRT1 signaling pathways.
Abu Bakar MH; Shariff KA; Tan JS; Lee LK
Eur J Pharmacol; 2020 Sep; 883():173371. PubMed ID: 32712089
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic inflammation in the control of metabolic function.
Valdearcos M; Xu AW; Koliwad SK
Annu Rev Physiol; 2015; 77():131-60. PubMed ID: 25668019
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue dysfunction contributes to obesity related metabolic diseases.
Blüher M
Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):163-77. PubMed ID: 23731879
[TBL] [Abstract][Full Text] [Related]
9. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
Goto T; Teraminami A; Lee JY; Ohyama K; Funakoshi K; Kim YI; Hirai S; Uemura T; Yu R; Takahashi N; Kawada T
J Nutr Biochem; 2012 Jul; 23(7):768-76. PubMed ID: 21889885
[TBL] [Abstract][Full Text] [Related]
10. Immune Cells and Metabolism.
Chatzigeorgiou A; Chavakis T
Handb Exp Pharmacol; 2016; 233():221-49. PubMed ID: 25903417
[TBL] [Abstract][Full Text] [Related]
11. The role of circadian clocks in metabolic disease.
Li MD; Li CM; Wang Z
Yale J Biol Med; 2012 Sep; 85(3):387-401. PubMed ID: 23012586
[TBL] [Abstract][Full Text] [Related]
12. Inflammation during obesity is not all bad: evidence from animal and human studies.
Ye J; McGuinness OP
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E466-77. PubMed ID: 23269411
[TBL] [Abstract][Full Text] [Related]
13. The inflammation highway: metabolism accelerates inflammatory traffic in obesity.
Johnson AR; Milner JJ; Makowski L
Immunol Rev; 2012 Sep; 249(1):218-38. PubMed ID: 22889225
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 1 in lipid metabolism and obesity.
Schug TT; Li X
Ann Med; 2011 May; 43(3):198-211. PubMed ID: 21345154
[TBL] [Abstract][Full Text] [Related]
15. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance.
Kim F; Pham M; Maloney E; Rizzo NO; Morton GJ; Wisse BE; Kirk EA; Chait A; Schwartz MW
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1982-8. PubMed ID: 18772497
[TBL] [Abstract][Full Text] [Related]
16. Obesity, inflammation, and macrophages.
Subramanian V; Ferrante AW
Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():151-9; discussion 159-62, 259-68. PubMed ID: 19346774
[TBL] [Abstract][Full Text] [Related]
17. Metaflammatory responses during obesity: Pathomechanism and treatment.
Debnath M; Agrawal S; Agrawal A; Dubey GP
Obes Res Clin Pract; 2016; 10(2):103-13. PubMed ID: 26614484
[TBL] [Abstract][Full Text] [Related]
18. Macrophages, immunity, and metabolic disease.
McNelis JC; Olefsky JM
Immunity; 2014 Jul; 41(1):36-48. PubMed ID: 25035952
[TBL] [Abstract][Full Text] [Related]
19. Fight against fibrosis in adipose tissue remodeling.
Li S; Gao H; Hasegawa Y; Lu X
Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E169-E175. PubMed ID: 34056922
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis.
Odegaard JI; Chawla A
Science; 2013 Jan; 339(6116):172-7. PubMed ID: 23307735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
